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Taste is one of the five senses and refers to the 
perception derived when chemical molecules stimulate 
receptors in the areas of the tongue, soft palate and 
oropharyngeal region of the oral cavity.1 The taste 
system plays a role in food selection and in a biological 
sense is subserved by five basic taste qualities: sweet, 
salty, sour, bitter and umami (savoury).1 These taste 
qualities allow humans to identify safe and nutritious 
foods appropriate for metabolic needs, or serve as a 
warning system for harmful foods, thereby increasing the 
chance of survival. The sense of taste also contributes 
to the pleasure or enjoyment experienced as part of 
eating and drinking (hedonics). The ability to perceive 
taste sensations guides food choice, which in itself is a 
determinant of health.2
Although the words ‘taste’ and ‘flavour’ have specific 
and distinct meanings in the sensory science literature,3 
they are often used interchangeably by patients and 
clinicians.4 The perception of flavour includes the sense 
of taste together with the senses of smell and touch. 
Flavour also includes inputs from temperature of food 
and drink or oral pain sensations (for example chili 
burn).5 Any problems with these sensory or hedonic 
elements of flavour can affect the enjoyment of food.
Cancer treatment can affect taste via several proposed 
physiological and psychological routes, including: an 
alteration in the number of normal taste cells; interruption 
in neural transmission of signals from taste receptors 
to the taste processing centre in the brain;5 secretion 
of chemotherapy drugs into saliva; and learned food 
aversions as a result of negative association between 
nausea inducing chemotherapy and certain foods.6 
This can manifest in: altered sensitivity to specific taste 
qualities (eg. sweet, salty); foods tasting different from 
usual; a bitter taste or metallic sensation in the mouth; 
or the rejection of particular foods as aversive to the 
patient.7 
In addition to a possible influence on the chemical 
sense of taste, cancer and its treatment is known 
to affect the senses of smell and touch, as well 
as cognition and hedonic experience of food and 
drink. Hedonic experience refers to a psychological 
determination of the extent to which eating and drinking 
is pleasurable.8 Food hedonics encompass food liking 
and appetite. These effects are associated with reduced 
food enjoyment, altered nutritional status and quality of 
life due to: reduced energy and nutrient intake;9 weight 
loss;3,10,11 impaired or altered desire to procure food; 
diminished food appreciation;12 changed patterns of 
food intake and rituals and social activities linked to 
eating and drinking;13,14 and emotional distress and 
interference with daily life.15-17 Disorders of taste are 
generally difficult to diagnose and treat, often because 
of a lack of routine assessment practices, as well as 
limited knowledge and understanding of this sense 
and its disease states.10 Whether, or to what extent, 
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changes to taste function play a role in reduced food 
enjoyment among people receiving chemotherapy is 
unknown. It is hypothesised however, as a result of a 
recently conducted systematic review,18 that problems 
with food liking and appetite occur independently of 
taste in people receiving chemotherapy. Additionally, 
the language of taste and flavour is important. 
Patient descriptions of how they experience particular 
sensations may provide the key to diagnosis of specific 
problems and can even suggest the course of therapy.19 
For example, a constant unpleasant oral sensation 
such as a “metallic taste” in the mouth may warrant 
different treatment to an increase in the perceived 
intensity of sweetness expressed as “food tastes really 
sweet”. The use of agreed terminology is fundamental 
to standardising words used to name a patient’s health 
problems or needs, and to enable clear descriptions 
of terms used by researchers.20 It is not until a clinical 
problem is adequately identified and described that it 
can start to be monitored and managed. 
The objective of this study was to determine whether 
and how taste or flavour problems are discussed with 
patients in the clinical oncology setting and to explore 
the needs of the cancer clinicians to better manage 
these symptoms. 
Methods
Part A: Dietitian’s documentation 
audit
A retrospective audit of dietitians’ medical 
note entries for 30 patients with head 
and neck cancer receiving nutritional care 
during the time period January to August 
2008 was conducted at Peter MacCallum 
Cancer Centre in Melbourne. The sampled 
documentation pertained to patients 
chronologically registered for treatment 
within the head and neck unit who were 
under the care of a dietitian. The hard 
copy medical history for each of these 
patients was examined by the researcher 
to isolate entries made by a dietitian during 
the study period. From each dietetic entry 
(n=200), the following data was extracted: 
whether taste or flavour problems were 
documented; the terms used by dietitians 
to document such problems; and any 
specific strategies documented to address 
the problems listed. Data was analysed 
using descriptive statistics and frequency 
counts.
Part B: Oncology clinician qualitative 
interview study 
Purposive sampling was utilised to recruit oncology 
nurses (n=6), medical oncologists (n=6) and oncology 
dietitians (n=11) with different levels of experience (table 
1) from two health care facilities to participate in face to 
face interviews. A semi-structured interview framework 
developed by an oncology dietitian and oncology nurse 
researcher was used as a basis to explore clinician 
practice. Two issues investigated during interview are 
reported in this publication: 
1. The language used by clinicians and patients to 
describe taste or flavour related problems. To 
investigate this issue, clinicians were asked: “What 
words do you actually use when you discuss taste? 
What words do patients use?” In this context, ‘taste’ 
was used by the researcher to determine if taste was 
being used as a defacto term for taste and flavour by 
clinicians. Interview data was analysed using content 
analysis based on a modified version of Melzack 
and Torgerson’s language of pain framework.19  In 
adapting this framework for relevance to taste and 
flavour, consideration was given to the sensory 
and hedonic elements associated with taste and 
flavour perception in humans. Categories and 
subcategories for patient and clinician descriptors 
of taste and flavour were identified. Reported terms 
and phrases were assigned to these categories. 
2. The needs of oncology clinicians to better manage 
taste or flavour problems. To investigate this issue, 
clinicians were asked: “If there was one thing you 
had at your disposal which helped patients with 
taste problems, what would it be?” Responses 
were categorised into themes identified by two 
independent researchers.
For each issue investigated, data items were highlighted 
and coded. Coded data items were then collated 
and sorted into potential categories in tabular form. 
Appropriateness of categories was discussed and refined 
in consultation with the supervising researcher (an oncology 
nurse), resulting in redefinition and collapse of some 
categories. Repeat categorisation of all coded data items 
were then conducted blindly by two authors, resulting 
Table 1: Sample characteristics of clinician participants in qualitative 
interview study. 
Variable
Oncology 
Nurses
Medical 
Oncologists
Dietitians Overall
Gender
 Male
 Female
   
2
4  
        
3
3
0
11
5
18
Age (years) 
(mean ± SD)
53.2 ± 3.2 45.3 ± 10.4 29.7 ± 4.7 39.9 ± 
12.0
Professional 
experience 
in oncology 
(years) 
(mean ± SD)
21.2 ± 7.1 15.1 ± 10.6 3.6 ± 3.6 11.2 ± 
10.1
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in 83% agreement after the first pass. 
Assignment of data items into categories 
were then compared and discussed 
among all authors. This process resulted 
in agreement of further sub-categorisation 
and re-assignment of data items until 
consensus for categorisation of each data 
item was attained.
Ethical approval to conduct these studies 
and publish the results was granted by the 
Ethics Committees of Peter MacCallum 
Cancer Centre and Eastern Health. 
Results
Part A: Dietitian’s documentation 
audit
The documentation of 10 dietitians 
across 30 patients was examined in this 
audit. A total of 89 of the 200 medical 
entries included some documentation 
of taste or flavour problems, made by 
nine dietitians. This represented 73% 
(22 of 30) of patients whose notes were 
audited. In total, 13 different terms were 
used by dietitians to describe taste 
and flavour problems in this head and 
neck cancer patient group (table 2). 
Only six of the 89 medical note entries 
which referred to taste or flavour clearly 
referred to the sense of taste (one of the 
five basic tastes). It was unclear whether 
the remaining entries referred to taste or 
other elements of flavour of food hedonics 
(sense of smell or touch, liking, appetite 
or cognitive processing), despite all but 
one phrase containing the word ‘taste’. 
Management strategies addressing taste 
or flavour problems were documented by 
four different dietitians on six occasions 
for five patients. Overall, while taste 
or flavour problems were documented 
for 73% of patients, only 23% also 
had documented plans for management 
of the problem. The wording of the 
documented strategies was non-specific 
(table 3).
Part B: Oncology clinician qualitative 
interview study 
Terms used by oncology clinicians and 
patients to describe the qualities and 
dimensions of taste and flavour problems 
fell into three distinct categories (sensory, 
hedonic and intensity). ‘Sensory’ refers to 
the human senses and ‘hedonics’ refers 
pleasure and displeasure. ‘Intensity’ may 
refer to sensory or hedonic properties. 
These categories were further broken 
down into seven sub-categories 
Table 3: Management strategies documented by dietitians in medical notes. 
 
Management strategy documented 
(actual wording) 
Number of instances 
phrase documented (n)
Discussed strategies to manage taste 
changes 
2
Discussed with patient taste changes 
may take many months to return and 
it is important despite this to eat well in 
order to maintain adequate nutrition
1
Discussed loss of taste 1
Encourage HPHE [high protein, high 
energy foods and fluids] despite lack of 
taste
1
Continue trying different foods while 
taste changes improve
1
Table 2: Terms used by dietitians to document taste and flavour problems. 
 
Documented term used to describe 
taste and flavour problems 
Number of instances 
term documented (n)
Taste changes1 30
Dysguesia 17
Lack of taste 12
Limited taste 7
Poor taste 5
Improving taste 4
Loss of taste 3
Fluctuating taste 3
Taste2 3
Limited sense of taste 2
Altered flavour perception 1
Hypoguesia 1
No sense of taste 1
1. On eight occasions, the description of taste problems was further characterised: “salty 
taste” n=6; “metallic” n=2
2. The word ‘taste’ was used as follows: “finds some foods unpalatable due to taste”, “still 
finds taste an issue”, and “taste OK”
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Table 4: Patient and clinician descriptors of taste and flavour problems.
Category and 
subcategory
Category definition
Terms used by patients (clinician 
reported)
Terms used by 
clinicians
Sensory taste Reference to the 
sensory properties of 
the five basic taste 
qualities: sweet, salty, 
sour, bitter or umami 
(Food tastes) really sweet 
(Food tastes) really salty 
Bitter 
Sensory smell Reference to the sense 
of smell
Metallic (food)
Metallic (taste in the mouth)
(Food tastes like) cardboard 
Straw 
(Food tastes like) crap 
(Food tastes like) shit 
(Food tastes like) wet carpet 
(Food tastes like) dirty socks 
Metallic
Sensory touch Reference to the 
sensory properties of 
touch and texture (eg. 
dryness)
Sandy
Chaff 
Cardboard
Hedonic wanting Reference to appetite, 
desire or motivation to 
eat food
Gone off foods No desire for food 
Hedonic liking Reference to the 
experience or 
anticipation of pleasure 
or displeasure from the 
oro-sensory stimulation 
of eating a food. 
Don’t like sweet foods anymore 
Can’t stand the taste of food 
Bad 
Yukky
Awful 
Foul 
Poison 
Horrible 
Loss of food enjoyment
Food tastes bad
Hedonic preference Reference to the 
selection of a food over 
relevant alternatives at 
the point of choice
Prefer sweet foods 
Prefer salty foods 
Prefer savoury foods
Intensity Reference to the 
relative magnitude of 
a sensory or hedonic 
element of flavour 
or the experience of 
eating
Food lacks flavour 
Tasteless 
Tastes of nothing 
No taste 
Lack of taste 
Loss of taste 
Everything tastes the same 
Can’t taste anything 
Like eating nothing 
Bland
Hypergeusia
Hypogeusia 
Bland 
No taste
Flat taste
Strong taste
Less strong taste
Food has lost its taste 
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(sensory-taste, sensory-smell, sensory-touch, hedonic-
wanting, hedonic-liking, hedonic-preference, intensity). 
Table 4 shows the assignment of reported terms to 
these categories and gives further detail of category 
definitions. Clinicians reported 34 terms used by 
patients and 13 terms used by clinicians to describe 
taste or flavour problems. Only three terms referred 
to true taste function and the remainder referred to 
elements of flavour (32), appetite (2) or food liking 
(10). The most common terms reported to be used by 
patients were “metallic”, “cardboard” and “no taste”. 
The range of terms used by clinicians was more limited 
than patients. There were many commonalities in 
terms used by clinicians and patients, but dietitians 
and doctors tended to also use more technical terms 
(such as ’dysgeusia’), which are reportedly reserved for 
discussion among clinicians rather than by clinicians 
with patients. 
In coding clinicians’ responses to the question of what 
is needed to better manage taste problems experienced 
by their patients, the central themes of ‘evidence’ 
and ‘information’ were identified. Evidence referred to 
reliable and credible scientific data required to inform 
practice. Information referred to practical and credible 
resource material which could be given to patients. 
Clinician responses pertaining to evidence and 
information were categorised in three main ways 
(characterising, supportive strategies and therapeutic 
devices). Table 5 shows the assignment of participant 
responses to these categories by the profession and 
gives further detail of category definitions. One of these 
categories (characterising) was further broken down 
into three sub-categories, characterising-assessment 
(does the problem exist), characterising-diagnostic tool 
(measurement techniques to determine which patients 
will experience what symptoms) and characterising-
predictors (who is at risk of a particular problem). 
Clinicians often specified the type of supportive 
strategy they were seeking, which included referral 
pathways, symptom relief, improved nutrition and 
food enjoyment. Nurses and dietitians (half of each 
group) most frequently identified supportive strategies 
which related to symptom relief, improved nutrition or 
enhanced food enjoyment to better support patients 
with taste or flavour problems. Supportive strategies 
identified by medical oncologists were linked to referral 
Table 5: Clinician identified mechanisms to improve management of taste and flavour problems. 
Key: Participant unique identifier follows individual quotes. D=Dietitian, N=Nurse, M = Medical Oncologist
Category Category description Clinician responses
Characterising
 - assessment
Characterising dimensions 
of the problem through 
better assessment 
techniques to determine 
whether one specific 
problem exists over 
another.
Glossary or classification of the different types of taste 
problems. D4
Specific information about the type of taste problem and 
specific strategies to try for each. If we knew which patients 
these ideas did work for then it would help us tailor better what 
we tell patients. D5
Being better equipped to classify the specific taste problem. 
D7
Test to pinpoint exactly what the taste problem was to enable 
the provision of an appropriate solution (eg. a diagnostic tool 
or an examination). D11
Characterising
– diagnostic tool
Characterising the 
problems dimensions 
through better diagnostic 
tools – the development of 
measurement techniques 
which enable diagnosis 
of specific problems and 
their underlying causes or 
aetiology.
Measurement of whether chemotherapy drugs are being 
secreted in the saliva and whether these are affecting taste. 
M6
Characterising
 - predictors
Characterising the 
problem trajectory through 
a better understanding of 
what problems are likely to 
arise at what time and of 
what nature for whom.
Better understanding of predictors of taste problems – which 
patients are more likely to experience certain types of taste 
changes – in order to forewarn patients of their likely symptom 
pattern in regards to taste. N1
Evidence of which chemotherapy regimens are more likely to 
cause taste alterations so we can forewarn patients. M1
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Category Category description Clinician responses
Supportive strategies Any supportive 
mechanism used in 
response to the problem, 
usually underpinned by 
evidence to guide practice 
or information for patients 
or clinicians. Typically 
in the area of referral 
pathways, symptom relief, 
improved nutrition or 
enhanced food enjoyment.
Resource folder including tips for different strategies depending 
on the nature of the taste problem. N3
Strategies which we knew worked. N4
More evidence, or a summary of findings (a collective body of 
knowledge) of things which have worked for some people. This 
info could be given to patients, but mostly for nurses to use to 
inform patients – i.e. for advice giving pre chemotherapy and 
also to revisit during treatment (when taste problems become an 
issue). N5
Referral to a dietitian. M1
A checklist of specific strategies to give to patients which might 
help. This would include creative tips for trying new foods and 
appropriate, cancer specific websites for recipes. M2
Access to a dietitian. M5
Information for patients which helped provide symptom relief, 
improved nutrition and improved food enjoyment. D3
Suggested strategies that could address each type of taste 
problem. D4
Good evidence on strategies which are helpful in supporting 
patients to achieve good nutrition for the taste changes they 
experience - I want to be able to sit with a patient who tells me 
they have this problem and be able to say something that is 
actually going to help. D6
Strategies to help depending on what the specific taste problem 
is. For example, having some strategies which assist in making 
food more edible for patients. D7
Evidence of what works. D10
Evidence-based practical solutions to whatever taste problem 
the patient raises. D11
Therapeutic device A medical tool to treat 
symptoms or cause of the 
problem.
Some type of available commercial product (eg a mouthwash) 
which was 1) effective in enhancing flavor or 2) stopping the 
metallic taste. N1
Some type of mouthwash or a longer course of steroids to be 
effective in getting patients to eat and enjoy their food. N2
Something magic to suck on which overrode the broken (taste) 
stimulus pathway – i.e. caused the new stimulus to trigger the 
neural pathway responsible for normal taste function. M3
A spray for the mouth that patients could use when they get the 
bad taste. M4
A (non-specified) therapeutic item. M6
A food additive which made food taste good during treatment. 
D8 
A preventative – a way of protecting or preserving the function of 
taste before it is lost. D8
Something which knocked off taste function altogether – this 
would be preferable to having all foods a patient eats tasting 
horrible. D9
Table 5: continued
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pathways (dietitian referral) rather than to symptom relief, 
improved nutrition or enhanced food enjoyment. Medical 
oncologists were more likely to identify therapeutic devices 
(50% of medical oncologist participant group) on their ‘wish 
list’ than were nurses (33%) or dietitians (27%). Therapeutic 
devices included a mouth spray or mouthwash (Table 5).
Discussion
From the dietitians’ documentation audit, it was clear that taste 
and flavour related complications in patients are frequently 
identified by this group of professionals, but with little or 
no distinction between the various aspects of flavour that 
might be affected by cancer therapies. Specific management 
strategies to address the identified problems were not 
observed. The qualitative interviews with oncology clinicians 
revealed that problems with taste, flavour or hedonics are 
currently all classified as ‘taste problems’. Taste and flavour 
complications include: changes to the sense of smell or 
touch (texture); reduced or heightened taste sensitivity; food 
aversions; offensive or phantom sensations (metallic); or the 
flavour of food perceived differently to what it previously did or 
resembling some other item or object. Additionally, food may 
taste the same but that taste is no longer pleasant.7 Both the 
audit and the interviews demonstrated that dietitians and other 
clinicians have limited capacity to distinguish between these 
differing side-effects of treatment.
Some clinicians cited a lack of evidence-based practice as 
a reason that discussing (and therefore treating) taste and 
flavour problems with their patients was difficult. Oncology 
clinicians report that strategies to manage taste and flavour 
problems are less concrete, or lack evidence, compared to 
strategies used to manage other toxicities of cancer treatment. 
For example, evidence-based clinical practice guidelines exist 
for mucositis and nausea and vomiting.21, 22 Routine methods 
of assessing taste and flavour related complications are 
not employed in the clinical oncology setting and no clinical 
guidelines exist for the management of problems with taste 
or flavour.
Regardless of whether problems pertain to taste, flavour 
or food hedonics, the end result for patients is likely to 
be decreased food enjoyment, which has implications for 
nutritional, gastronomical and social domains of life quality. 
Further research is now needed to develop a taxonomy of 
taste, flavour and food hedonics, which may give clinicians 
better diagnostic clues to the precise nature of these problems 
and inform the design and testing of interventions to ameliorate 
specific symptoms. 
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